ZARONTIN NEWS HIGHLIGHTS
Media Articles Related to Zarontin (Ethosuximide)
Vimpat(R) Approved In Europe - First New Epilepsy Treatment For Partial-Onset Seizures In Three Years
Source: Epilepsy News From Medical News Today [2008.09.03]
Pediatric Epilepsy Surgery
Source: MedicineNet Cerebral Palsy Specialty [2008.08.26]
Investigational Epilepsy Drug Slims Down Fat Rats
Source: MedPage Today OB/GYN [2008.08.25]
Epilepsy Linked To Higher Risk Of Drowning
Source: Epilepsy News From Medical News Today [2008.08.19]
Epilepsy Raises Drowning Risk
Source: MedicineNet Seizure Specialty [2008.08.19]
Published Studies Related to Zarontin (Ethosuximide)
Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy? [2007.04]
Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. [2006.11]
Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. [2006.09]
7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. [2006.09]
The effects of ethosuximide on amino acids in genetic absence epilepsy rat model. [2006.03]
Clinical Trials Related to Zarontin (Ethosuximide)
Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Type I [Not yet recruiting]
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study [Active, not recruiting]
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy [Recruiting]
|
